Shree Ram Proteins Limited (SRPL) fair value: what the stock is really worth
As of Oct 19, 2026: fair value (intrinsic value) of Shree Ram Proteins Limited stock ₹0.78, price ₹0.34, upside +129.4%, quality 54 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.
How to read this chart
60‑month range ₹0.3300 – ₹13.41 · fair‑value band ₹0.5100 – ₹0.9700 · the ₹0.3400 price screens below the ₹0.7800 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 4, 2026.
Follow Shree Ram Proteins in your weekly email
Every Wednesday you see whether Shree Ram Proteins is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Shree Ram Proteins Limited engages in cotton seeds extraction business in India. Its products include cotton linter, seed hull, seed meal, seed wash oil, and seed refine oil; and soyabean meal, rapeseed meal, groundnut meal, and raw cotton bales. The company also exports its products.
Show moreShow less
Shree Ram Proteins Limited was incorporated in 2005 and is based in Rajkot, India.
Stock analysis
Shree Ram Proteins Limited (SRPL) currently trades at ₹0.3400, while our model-based Fair Value estimate is ₹0.7800, implying the stock looks roughly 56.4% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the data coverage at low.
Scenario range: ₹0.5100 (bear) to ₹0.9700 (bull), the price of ₹0.3400 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Consumer Defensive sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Shree Ram Proteins Limited reported revenue of ₹0 in FY2026 versus ₹2.9B in FY2022. Reported net income was −₹101M in FY2026.
Key figures
Market cap ₹72.8M (≈ $768K) Micro · P/S ratio 5.14 · EPS (TTM) ₹−0.6900 · Return on equity −59.4% · Return on assets (EBIT) −4.9% · Operating margin −39.8% · Revenue (TTM) ₹14.2M · EPS growth (YoY) −84.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 5 out of 100 (low confidence).
What moves the price
The share trades about 55% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at 129%, SRPL screens cheaper than that median.
Fair Value models
Bear₹0.5100Fair Value ₹0.7800Bull₹0.9700
Price ₹0.3400 · Upside +129.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.8/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−90.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−54.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−37.8%
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−17.1%
’13
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
5.1% (2019) → −61.2% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+32.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +27.2% a year for the price.
Compare Shree Ram Proteins Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 293 stocks
Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score54 · Above median
Fair Value upside+129.4% · Top 25%
Profitability
Return on assets−14.6% · Bottom 25%
Operating margin (12 months)−39.8% · Bottom 25%
Balance sheet
Debt / equity1.11× · Highest 25%
Valuation Multiplesvs Farm Products median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Shree Ram Proteins Limited (SRPL) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of ₹0.7800 versus a price of ₹0.3400, about +129% upside (undervalued).
What is the fair value of SRPL?
Our model-based fair value for Shree Ram Proteins Limited is ₹0.7800 (as of Oct 4, 2026), built from audited fundamentals. The current price: ₹0.3400.
What is the quality score of SRPL?
Shree Ram Proteins Limited has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Shree Ram Proteins Limited (SRPL)?
Our model-based price target is the fair value of ₹0.7800 (as of Oct 4, 2026) from 1 valuation models. Cautious scenario ₹0.5100, optimistic scenario ₹0.9700. It is a calculation from audited fundamentals, not an analyst target.
What is the Shree Ram Proteins Limited stock forecast for 2026?
Our models put fair value at ₹0.7800, about +129% upside versus a price of ₹0.3400 (undervalued). Cautious scenario ₹0.5100, optimistic scenario ₹0.9700. The calculation is refreshed regularly with new filings.
What is the revenue of Shree Ram Proteins Limited (SRPL)?
Shree Ram Proteins Limited reported trailing-twelve-month revenue of about ₹14.2M (latest available figure, as of Oct 4, 2026).
What growth is priced into Shree Ram Proteins Limited (SRPL)?
For today's price to be fair in a discounted-cash-flow model, Shree Ram Proteins Limited would have to grow free cash flow by +32.5 % per year for five years (discount rate 12.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -37.8 % per year. As of Oct 4, 2026.
What discount rate (WACC) does the fair value of SRPL use?
Our models discount Shree Ram Proteins Limited at 12.4 %: a base by market capitalisation (nano), country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Shree Ram Proteins Limited that is +32.5 % per year a year over ten years, using the same discount rate (12.4 %) and the same formula as our fair value.
How much growth has Shree Ram Proteins Limited (SRPL) delivered so far?
Over the past 5 years revenue at Shree Ram Proteins Limited grew -37.8 % a year. The price currently implies +32.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Shree Ram Proteins Limited (SRPL) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Shree Ram Proteins Limited (+32.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Shree Ram Proteins Limited (SRPL)?
The free-cash-flow yield on the price is 13.37 %: that much free cash flow Shree Ram Proteins Limited produces per unit of market value. When it exceeds the discount rate of our models (12.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Shree Ram Proteins Limited (SRPL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Shree Ram Proteins Limited it is ₹0.7800 per share (as of Oct 4, 2026), against a price of ₹0.3400. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Shree Ram Proteins Limited stock overvalued or undervalued in 2026?
As of Oct 4, 2026, SRPL trades below its calculated fair value: price ₹0.3400, fair value ₹0.7800, a gap of about +129% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SRPL?
No. The price is what the market pays today (₹0.3400); the fair value is what the company's own numbers justify (₹0.7800). For Shree Ram Proteins Limited the two are ₹0.4400 per share apart. That gap is exactly why we show both numbers side by side.
How much is Shree Ram Proteins Limited worth?
The market values Shree Ram Proteins Limited at about ₹72.8M (market capitalisation, as of Oct 4, 2026). Per share that is ₹0.3400; our models calculate a fair value of ₹0.7800 per share.
What do the bullish and bearish scenarios say about SRPL?
Our models span a range for Shree Ram Proteins Limited: cautious scenario ₹0.5100, base ₹0.7800, optimistic ₹0.9700 per share (as of Oct 4, 2026, price ₹0.3400). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Shree Ram Proteins Limited (SRPL)?
Balance-sheet figures for Shree Ram Proteins Limited (as of Oct 4, 2026): return on equity −59.4%, debt of 1.11 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is SRPL from its 52-week high?
Shree Ram Proteins Limited trades at ₹0.3400, about 55% below its 52-week high of ₹0.7600 and 3% above the low of ₹0.3300 (as of Oct 19, 2026). Distance from the high says nothing about value: that is what the fair value of ₹0.7800 is for.
Which stocks are comparable to Shree Ram Proteins Limited?
From the same area (Consumer Defensive) we also value Archer-Daniels-Midland Company, Muyuan Foods Group, Bunge Global SA, Tyson Foods, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Shree Ram Proteins Limited stock attractive at the current price?
The data as of Oct 4, 2026: price ₹0.3400, calculated fair value ₹0.7800 (+129%), Quality Score 54/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SRPL calculated?
We run Shree Ram Proteins Limited through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹0.7800, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.8 % above its aggregate fair value. Shree Ram Proteins Limited currently trades 56 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Shree Ram Proteins Limited (SRPL)?
The closing price on Oct 19, 2026 was ₹0.3400. Our model-based fair value is ₹0.7800, about +129% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Shree Ram Proteins Limited right now?
The price is below even our cautious bear case (₹0.5100). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (₹0.5100 to ₹0.9700) leaves room in how you read the outcome.
Key figures of Shree Ram Proteins Limited
How large is the market capitalisation of Shree Ram Proteins Limited (SRPL)?
The market capitalisation of Shree Ram Proteins Limited is ₹72.8M (≈ $768K). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Shree Ram Proteins Limited (SRPL)?
The price-to-sales ratio of Shree Ram Proteins Limited is 5.14 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Shree Ram Proteins Limited (SRPL)?
Earnings per share at Shree Ram Proteins Limited are ₹−0.6900. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Shree Ram Proteins Limited (SRPL)?
The return on equity (ROE) of Shree Ram Proteins Limited is −59.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Shree Ram Proteins Limited (SRPL)?
On an EBIT basis the return on assets of Shree Ram Proteins Limited is −4.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Shree Ram Proteins Limited (SRPL)?
The operating margin of Shree Ram Proteins Limited is −39.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast are earnings growing at Shree Ram Proteins Limited (SRPL)?
Earnings per share at Shree Ram Proteins Limited are growing −84.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Shree Ram Proteins Limited (SRPL) carry?
The net debt of Shree Ram Proteins Limited is ₹371M (fiscal year 2026, ≈ 38.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Shree Ram Proteins Limited in the live analysis
One click puts Shree Ram Proteins Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 4, 2026